Venrock Healthcare Capital Partners III, L.P. - Dec 26, 2023 Form 3 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)

Role
10%+ Owner
Signature
Venrock Healthcare Capital Partners III, L.P., By: VHCP Management III, LLC, Its: General Partner, By: /s/ Sherman G. Souther, Authorized Signatory
Stock symbol
KALV
Transactions as of
Dec 26, 2023
Transactions value $
$0
Form type
3
Date filed
12/28/2023, 04:28 PM
Next filing
Dec 29, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding KALV Common Stock 3.57M Dec 26, 2023 By Funds F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of (i) 845,086 shares held by Venrock Healthcare Capital Partners III, L.P. ("VHCP3"); (ii) 84,538 shares held by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3"); and (iii) 2,644,090 shares held by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG").
F2 VHCP Management III, LLC ("VHCPM3") is the general partner of VHCP3 and the manager of VHCP Co-3 and may be deemed to beneficially own these shares. VHCP Management EG, LLC ("VHCPMEG") is the general partner of VHCPEG and may be deemed to beneficially own these shares. Bong Koh and Nimish Shah are the voting members of VHCPM3 and VHCPMEG and may be deemed to beneficially own these shares. Each of VHCPM3, VHCPMEG and Messrs. Koh and Shah expressly disclaims beneficial ownership over these shares except to the extent of its or his indirect pecuniary interest therein.